Skip to Content
Global News Select

Anthem 3Q Profit Falls, Revenue Rises

By Dave Sebastian

Anthem Inc. said its profit for the September quarter fell as expenses grew, and revenue rose due to higher premiums.

The health insurer Wednesday posted net income of $222 million, or 87 cents a share, compared with $1.18 billion, or $4.55 a share, in the year-ago period. Net negative adjustment items were $3.33 a share. Adjusted earnings were $4.20 a share.

Analysts polled by FactSet were expecting earnings of $3.85 a share, or $4.12 a share on an adjusted basis.

The medical-loss ratio, the share of premiums the insurer pays out in claims, was 86.8%. Analysts were expecting 87%. The ratio decreased from 87.2% in the year-ago period due to the deferral of health care amid the Covid-19 pandemic.

Revenue rose to 16.8% to $31.16 billion, driven by higher premium revenue due to growth in Medicaid and Medicare, pharmacy-product revenue related to the launch of IngenioRx and the return of the health insurance tax in 2020. Analysts were looking for $29.86 billion.

Expenses grew 22.2% to $30.77 billion.

The company had 42.6 million members as of Sept. 30, up 172,000 from June 30. Members in the company's government business grew 453,000 due to Medicaid and Medicare Advantage. The company's commercial and specialty business enrollment fell 281,000.

Write to Dave Sebastian at dave.sebastian@wsj.com

(END) Dow Jones Newswires

October 28, 2020 06:35 ET (10:35 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.